red blood cell alloimmunization in patients with thalassemia major and intermediate in southwest iran

Authors

keikhaei b

hirad far a

abolghasemi h

mousakhani h

abstract

background: transfusion is the mainstay treatment of patients with thalassemia major and occasionally in thalassemia intermediate. alloimmunization is an unwanted side effect of blood transfusion. the present study intended to determine the frequency of alloimmunization in patients with β- thalassemia major and thalassemia intermediate in southwest iran. patients and methods: this was a cross-sectional study on 133 transfusion dependent β-thalassemia patients at shafa hospital-in southwest iran. the method of antibody screening was the tube method. all panel test phases were done at immunohematology laboratory of iranian blood transfusion organization. results: there were 66 males (49.1%) and 67 females (50.9%) with the mean age of 17.5 years (sd±7.5) included in this study. the antibody screening panel test was positive in 42 patients (32.06%). twenty five patients (18.7%) had alloantibody and 17 patients (12.7%) also had autoantibody. the predominant pattern of alloimmunization was alloantibodies against rh sub groups system in 55 percent of patients and 33% of patients had alloantibodies against kell system. three important factors that significantly influenced the frequency of alloimmunization were: age at the first blood transfusion, splenectomy and β- thalassemia intermediate. conclusion: alloimmunization is a common complication among patients with transfusion dependent β-thalassemia in khuzestan province, iran. matching the selected donors with recipients based on the extended red blood cell antigen typing may decrease the incidence of alloimmunization. key words: alloimmunization, thalassemia major, thalassemia intermediate, rh blood group, kell blood group.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Red Blood Cell Alloimmunization in Patients with Thalassemia Major and Intermediate in Southwest Iran

Background: Transfusion is the mainstay treatment of patients with thalassemia major and occasionally in thalassemia intermediate. Alloimmunization is an unwanted side effect of blood transfusion. The present study intended to determine the frequency of alloimmunization in patients with β- thalassemia major and thalassemia intermediate in Southwest Iran. Patients and Methods: This was a cross-...

full text

Frequency and Risk Factors of Red Blood Cell Alloimmunization in Thalassemia Major Patients in Markazi province

Background: Thalassemia is one of the most common genetic disorders throughout the world. Blood transfusion plays an important role in the treatment of thalassemia but it leads to numerous complications such as iron overload and alloimmunization. This study evaluated the frequency and risk factors associated with alloimmunization in thalassemia major patients living in Markazi province, Iran. ...

full text

Red Blood Cells Alloimmunization and Autoimmunization in Multi-transfused Thalassemia Patients in South of Iran

Background: Recurrent blood transfusion is a common treatment in patients with thalassemia. The development of antibodies against red blood cell (RBC) antigens complicates RBC cross-matching, enhances the in vivo destruction of transfused cells, accelerates tissue iron overloading, delays the provision of safe transfusion, and reduces health-related quality of life. Materials and Methods: In t...

full text

Quality of Life and Some Related Factors in Patients With Beta Thalassemia Major in Southwest Iran

Background: Thalassemia is one of the most common genetic disorders in the world, especially in Iran. The study of various aspects affecting the physical and mental health of patients with beta thalassemia major has become more important. The aim of this study was to evaluate the Quality of life and some related factors in patients with beta-thalassemia major in Southwest Iran. Methods: In thi...

full text

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia

Background Sickle hemoglobin is the most common abnormal hemoglobin in the United States. Hemoglobin S arises as a result of a single amino acid substitution (glutamic acid to valin at position 6 of the β-globine chain). The presence of fetal hemoglobin (HbF) plays a relatively protective role since a significant amount of HbF interferes with HbS polymerization, the pathogenesis mechanism of ...

full text

Responder individuality in red blood cell alloimmunization.

Many different factors influence the propensity of transfusion recipients and pregnant women to form red blood cell alloantibodies (RBCA). RBCA may cause hemolytic transfusion reactions, hemolytic disease of the fetus and newborn and may be a complication in transplantation medicine. Antigenic differences between responder and foreign erythrocytes may lead to such an immune answer, in part with...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of blood and cancer

جلد ۶، شماره ۱، صفحات ۴۱-۴۶

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023